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Novel mesoporous silica nanoparticles (LPMSNs) functionalised with degradable poly(2-dimethyl-
aminoethyl acrylate) (PDMAEA) have been developed (PDMAEA–LPMSNs) as nano-carriers for gene
delivery. The unique design of PDMAEA–LPMSNs has endowed this system with multiple functions
derived from both the organic and inorganic moieties. The cationic polymer unit binds to genetic
molecules and undergoes a self-catalyzed hydrolysis in water to form a non-toxic anionic polymer
poly(acrylic acid), allowing controlled release of siRNA in the cells. The nanopores of the LPMSNs provide
a reservoir for storage and release of chloroquine to facilitate endosomal escape. The PDMAEA–LPMSN
composites were characterized by elemental analysis (EA), X-ray photoelectron spectroscopy (XPS),
solid-state 13C magic-angle spinning nuclear magnetic resonance (MAS-NMR), thermogravimetric
analysis (TGA), and nitrogen sorption techniques. Their siRNA delivery performance was tested in a KHOS
cell line, showing promising potential for co-delivery of genes and drugs.Introduction
Small interfering RNA (siRNA) based therapeutics has received
increasing attention for cancer treatment applications.1 The
siRNA therapy features highly specic siRNA to silence onco-
genes. However, the vulnerability of siRNA to nucleases and its
poor cellular delivery hampers in vivo applications.2 Nano-
carriers that can package, protect and deliver siRNA to the tar-
geted site hold promise for solving these problems for practical
applications in siRNA therapy.3
Various nanocarriers have been developed for delivery of
siRNA, such as lipid and polymer based carriers.4 Inorganic
materials (e.g. gold, iron oxide and silica materials) have also
been studied as carriers for genetic molecules.5–8 Recently,
mesoporous silica nanoparticle (MSN) based materials have
shown promising performance as gene carriers.9–11 Various
surface modied MSN have been systematically studied to
deliver siRNA. Short amine silanemoieties have been extensively
used to increase silica aﬃnity towards the nucleic acid agents
(DNA, siRNA).9–11 Meng et al. used polyethyleneimine (PEI)nd Nanotechnology, The University of
. E-mail: m.monteiro@uq.edu.au; c.yu@
versity of Adelaide, Adelaide, Australia.
(ESI) available: Nitrogen sorption and
DMAEA–LPMSN; high resolution XPS
. See DOI: 10.1039/c3tb21015d
26modied MSNs with diﬀerent molecular weights to enhance the
eﬃcacy of siRNA.12 In addition, polyamine dendrimer–MSNs
have also been used for delivering siRNA.13 Composite materials
consisting of both polymer and mesoporous silica combine the
benets from each component to create amore advanced carrier
system.8,13,14 Polycation or polyamine complexes with MSN are
more versatile compared to the short chain amine-MSNs. The
presence ofmulti aminemoieties signicantly enhances particle
aﬃnity towards siRNA and the cell membrane.15
The main issue related to the polycation complex with siRNA
(polyplex) is the strong binding between the abundant positive
charge on the polymer and the negatively charged phosphonic
acid of the nucleic acid, which hinders the release of siRNA
within the cytoplasm thus lowering the eﬃcacy of the siRNA.16,17
This factor is also known as vector unpacking. To exert siRNA
function, it needs to be transferred into the cytoplasm and
released from the carrier as free molecules which can induce
gene silencing.18,19 The second issue is the cytotoxicity of the
polycation.17 This condition raises a concern about the
accumulated toxicity of the nanoparticles, especially aer multi-
administration. Previously, we have reported the use of poly-L-
lysine (PLL) functionalised large pore mesoporous silica
nanoparticles (LPMSN-P) as gene carriers.15 The PLL-function-
alized nanoparticles bound strongly to the nucleic acid mole-
cules and delivered oligoDNA-Cy3 (amodel for siRNA) eﬃciently
to HeLa cells. However, the low release of siRNA from the
complex limited the eﬀectiveness of this system.
Degradable polycationic polymers that can be degraded into
non-toxic compounds and enhance gene release are preferableThis journal is © The Royal Society of Chemistry 2014
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View Article Onlineas carriers in gene therapy.16 Several methods have been used to
establish degradable structures by introducing cleavable bonds
into the polymer structures. The cleavable bonds include esters,
amides, carbonates and disuldes. Most of these structures
depend on various external triggers (pH, redox potential and
enzymes) to start the degradation.17,20–22 However, the high
uctuation of these triggers within the human bodymight cause
inconsistency in the cleavage reactions, resulting in variable and
unpredictable rates of degradation.23,24 It is desirable to use a
cleavable polymer that degrades only aer being internalized by
target cells in a simple and controlled manner.23,24
Recently, a self-catalyzed degradable cationic polymer (poly(2-
dimethylaminoethyl acrylate), PDMAEA), which degrades
independently of an external degradation trigger, has been
developed.23–25Thedegradation product is poly(acrylic acid), PAA,
which is non-toxic. The most prominent features of this polymer
are the ability to bind and protect oligo-DNA for suﬃcient time
and the capacity to release the DNA inside the cells aer 10
hours.23–25 In this work, we used PDMAEA covalently attached to
the surface of large pore mesoporous silica nanoparticles
(PDMAEA–LPMSNs) to act as a dual delivery system. The surface
bound PDMAEA can bind and release siRNA ‘on-demand’.
Chloroquine was loaded in the nanopores of the LPMSNs as a
model drug which helps endosomal escape. It was shown that
PDMAEA–LPMSNs releasedoligo-DNA (mimicking siRNA)within
2 days of incubation, while little release was observed from the
polyethyleneimine (PEI) functionalized LPMSNs. In the delivery
of a functional siRNA (PLK1), chloroquine loaded PDMAEA–
LPMSNs inhibited the viability of KHOS cancer cells signicantly
compared to PDMAEA–LPMSNs, showing the advantage of a
carefully designed composite co-delivery system.
Experimental section
Chemicals
Triblock poly(ethylene oxide)-b-poly(propylene oxide)-b-poly-
(ethylene oxide) copolymer EO106PO70EO106 (Pluronic F127,
MW ¼ 13 400), tetraethoxysilane (TEOS, 99%), 1,3,5-trime-
thylbenzene (TMB), copper(I) bromide, 3-glycidoxypropyl tri-
methoxysilane (3-GPS), 3-aminopropyltriethoxysilane (APTES,
99%), sodium azide, ethyl 2-chloropropionate (97%), copper
powder (size < 425 mm, 99.5% trace metals basis), tris[2-(dime-
thylamino)ethyl]amine were used as received from Sigma
Aldrich. A uorocarbon surfactant (FC-4) was purchased from
Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd. 2-(Dimethyla-
mino) ethyl acrylate (98%), N,N-dimethylacrylamide (99%) were
passed through a column of basic alumina to remove the
inhibitor before use. n-Hexane (>98%), dichloromethane
(99.8%), and methanol (99.8%) were used as received from
Merck. Polyethyleneimine (PEI) (MW: 10 kDa) were purchased
from Alfa Aesar (Ward Hill, MA). All chemicals were used as
received without purication. Cell lines used: osteosarcoma cell
line KHOS/NP (CRL-1544™) was purchased from ATCC (Amer-
ican Type Culture Collection). Twenty-one-nucleotide (oligo)
DNA conjugated with cyanine dye (Cy-3), fetal calf serum,
paraformaldehyde and anti-fade uorescent mounting medium
with 40-6-diamidino-2-phenylindole (DAPI) were purchasedThis journal is © The Royal Society of Chemistry 2014from Sigma Aldrich. Dulbecco's Modied Eagle's Medium
(DMEM) and penicillin G, streptomycin sulphate and L-gluta-
mine mixture were from Gibco-Invitrogen. The CellTiter-Glo®
cell viability assay kit was from Promega. Synthetic human PLK1
was purchased from Ambion at Applied Biosystems (Foster City,
CA). The siRNA sequences are: PLK-S: 50-CCAUUAACGAGCUG
CUUAATT-30; PLK-AS: 50-UUAAGCAGCUCGUUAAUGGTT-30. S10-
siRNA was synthesized by Proligo (Lismore, Australia) and the
sequence: S10-S: 50-GCAACAGUUACUGCGACGUUU-30; S10-AS:
50-ACGUCGCAGUAACUGUUGCUU-30.Synthesis of LPMSNs
LPMSNs were synthesised following a previous method by Ying
et al.26 First, 0.5 g F127 and 1.4 g of FC-4 were dissolved in 60 ml
of 0.02 MHCl and stirred for 24 hours at 60 C. 0.4 g of TMB was
added into the mixture and stirred at a temperature of 30 C for
6 hours. Then, 3 g of TEOS was added to the solution, and the
stirring process was continued at 30 C for another 24 hours.
The solution was then transferred into autoclaves for hydro-
thermal treatment. The hydrothermal temperature was at
100 C for 24 hours. The sample was denoted as as-synthesized
LPMSNs (AS-LPMSNs). The surfactant (F-127) still remained
within the pores of the AS-LPMSNs.Synthesis of 2-bromo-N-(3-(triethoxysilyl)propyl)propanamide
BPB in 50mlDCMwas addeddropwise to a cold solution of APTS
and TEA in 200 ml dry DCM. The solution was stirred for 30 min
at room temperature and the precipitate was ltered oﬀ. The
solution was washed with acidic water and dried with magne-
sium sulphate. Aer ltration the solvent was removed using a
rotavapor. The product was dried under vacuum for 24 hours.Azidation of 2-bromo-N-(3-(triethoxysilyl)-propyl)
propanamide or azide silane
BPTS was dissolved in dry DMF and NaN3 was added. The
mixture was stirred for 48 hours at room temperature. The
solution was then diluted with 200 ml of DCM, washed with
water and concentrated by evaporation. The product was dried
under vacuum for 24 hours.J. Mater. Chem. B, 2014, 2, 718–726 | 719
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View Article OnlineSynthesis of poly(2-dimethylaminoethyl acrylate) (PDMAEA)
by SET-LRP27
CuCl2/Me6TREN (32 mg, 8.8  105 mol), Me6TREN (61 mg,
2.6  104), ethyl 2-chloropropanoate (120 mg, 8.8  104
mol) and 2-dimethylaminoethyl acrylate (DMAEA, 18.9 g,
0.132 mol) were dissolved in isopropanol (10 ml) and the
solution was purged with argon for 30 minutes at room
temperature. Cu powder (size < 425 mm) was added under an
argon ow. Aer 7 hours of polymerisation at room tempera-
ture, the solution was diluted with acetone (100 ml) and
passed through Al2O3 to remove the copper. Acetone was
removed using the rotavap, and the product was obtained by
precipitation in a large excess of cold n-hexane (500 ml) and
then isolated by centrifugation. This procedure was repeated
three times. The polymer was dried under a high vacuum for
48 hours at room temperature to give a yellow oily product
(yield 70%). The conversion of the polymerization was 40% as
determined by 1H NMR spectroscopy. Mn ¼ 4200, PDI ¼ 1.29
(SEC-RI calibrated using P(STY) standards and DMAc + 0.03
wt% LiCl was used as the eluent).Synthesis of azide–MSNs (A–MSNs) and PDMAEA–LPMSNs
To establish azide groups on the surface of the LPMSNs, 5.3 mg
2-azido-N-(3-(triethoxy silyl)propyl)propanamide or azide silane
was graed onto 100 mg AS-LPMSNs in 25 ml toluene. The
reaction was maintained at 70 C for 24 hours. The product was
washed with toluene and methanol and followed by surfactant
removal. The surfactant removal was conducted using an
extraction process in acidic-methanol for 24 hours and the
process was repeated three times. The product is named
A–MSNs. A–MSNs have an opened pore structure.
Finally, a click reaction between alkyne-poly(2-dimethyla-
minoethyl acrylate) (PDMAEA) and A–MSN also known as the
Huisgen 1,3-dipolar cyclo-addition can be conducted. 100 mg
A–MSNs and 578 mg PDMAEA was mixed in 2 ml of toluene at a
room temperature under argon, followed by addition of 9 ml of
PMDETA. Then, 6 mg of copper bromide (CuBr), as a catalyst,
was added to the mixture. The reaction was maintained for 24
hours. The product PDMAEA–LPMSNs were washed and dried
in a vacuum.Synthesis of PEI-LPMSNs
First the epoxysilane was attached onto the silica surface: 100
mg of LPMSNs were mixed in 30 ml of toluene and stirred for 15
minutes at 70 C. 1.5 ml of 3-GPS was added into the solution
and further stirred for 24 hours at the same temperature. The
solid products (epoxy-LPMSNs) were centrifuged, washed with
toluene and methanol three times, and dried. The next step was
to gra PEI onto the epoxy-LPMSNs: 80 mg of epoxy modied
particles were mixed with 200 mg PEI (10 kDa) in 100 ml of
carbonate buﬀer (50 mM, pH 9.5) for 24 hours at room
temperature. Aer this step, the solid product was produced
and washed with 20 ml of 1.0 M NaCl and water three times,
then centrifuged. At the nal stage, the solid products were
suspended in 20 ml of 1.0 M ethanolamine (pH 9) and stirred at720 | J. Mater. Chem. B, 2014, 2, 718–726room temperature for 6 hours to block unreacted epoxy
groups. The solids were again washed with 20 ml of 1.0 M NaCl
and 20 ml water.
Adsorption of chloroquine onto the PDMAEA–LPMSNs
100 mg of A–MSNs were mixed with 80 ml of chloroquine (Chl)
solution (100 mg ml1). The suspension was incubated for 24
hours at room temperature under constant stirring. The
suspension was then separated by centrifugation. The ChI
concentration was determined before and aer incubation
using UV–vis at a wavelength of 329 nm. The diﬀerence in Chl
amounts is determined as the amount of Chl absorbed on the
material. The adsorption was then followed by PDMAEA
attachment onto Chl loaded A–MSN. The sample is denoted
Chl–PDMAEA–LPMSN.
Oligo DNA adsorption and release analysis
Oligo DNA was complexed with PDMAEA–LPMSN (or PEI–
LPMSN) at 2 diﬀerent nitrogen to phosphorous ratios (N/P)
(N/P ¼ 1 and 10). The complex was mixed in 25 ml of water
for 30 minutes at room temperature. Oligo DNA and LPMSN–
oligo DNA were used as controls. The agarose gel retardation
assay was initiated by adding 5 ml DNA loading dye into the
complex which was then loaded into a 2% agarose gel con-
taining TAE buﬀer and stained with ethidium bromide. The
gels were run in 1 TAE buﬀer for around 10 minutes at 80 V
and then followed by observation under a Bio-Rad UV
transilluminator.
Cytotoxicity test
The cytotoxicity of the PDMAEA–LPMSNs and the Chl–
PDMAEA–LPMSNs in KHOS cells were tested by Cell-Titer Glo
assay. KHOS cells were seeded in a 96-well cell culture plate
with a density of 5  103 cells per well. Aer incubation for
24 hours, the cells were treated with diﬀerent concentrations
of PDMAEA–LPMSN and Chl–PDMAEA–LPMSN solution, fol-
lowed by further incubation at 37 C for 48 hours. The cell
viability of KHOS cells was evaluated using a Cell-Titer Glo
assay, according to the protocol provided by the manufac-
turer. The cells incubated in the absence of particles were
used as the control. All the experiments were performed in
triplicates for each group. The statistical data are shown as
mean  (SD).
Cellular uptake (confocal microscopy)
KHOS cells were maintained in Dulbecco's Modied Eagle
Medium (DMEM) supplemented with fetal calf serum (10%), L-
glutamine (2%), penicillin (1%), streptomycin (1%) in 5% CO2
at 37 C. The medium was routinely changed every 2 days and
the cells were separated by trypsinisation before reaching
conuency. KHOS cells were seeded in a 6-well plate (1  105
cells per well) and incubated for 24 hours prior to the cell
uptake assay. 50 mg of PDMAEA–LPMSNs or Chl–PDMAEA–
LPMSNs and 2 ml of 100 mM Cy3-oligoDNA was mixed in 100 ml
of phosphate buﬀered saline (PBS) solution and incubated atThis journal is © The Royal Society of Chemistry 2014
Fig. 1 TEM images of (A) LPMSNs and (B) PDMAEA–LPMSNs (scale bar:
100 nm).
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View Article Online4 C overnight. Aer incubation, the mixture was added to a
well in a 6-well plate containing 2.0 ml of serum-free DMEM
medium, and the nal concentrations of nanoparticles and
Cy3-oligoDNA were 25 mg ml1 and 100 nM, respectively. Aer
incubation for 4 hours at 37 C, the cells were washed twice
with PBS to remove the remaining nanoparticles, free Cy3-
oligoDNA and dead cells. For xed cell imaging, the cells were
treated with 500 ml of 4% PFA PBS solution for 30 minutes at
4 C, and their nuclei were stained with DAPI for 10 minutes.
Finally, the cells were observed under a confocal microscope
(LSM Zeiss 710).
siRNA function
To examine whether the particles (PDMAEA–LPMSN and Chl–
PDMAEA–LPMSN) can deliver functional molecules to cells for
therapy, we chose siRNAs against human PLK1 genes (PLK1-
siRNA). An ineﬀective siRNA, S10-siRNA, was chosen as a
negative control because S10-siRNA is eﬀective only against
human papillomavirus (HPV) type E6 gene, while there is no
HPV in KHOS cells. The cells were seeded at 5  103 cells per
well in 100 ml of complete DMEMmedium in a 96-well plate and
cultured overnight before treatment. The siRNA was absorbed
onto particles as described above (for 21-nucleotide oligo DNA
adsorption) and were added to the cells. The cells were treated
for 48 hours and the silencing eﬀect or cell viability was deter-
mined by Cell-Titer Glo assay.
Characterization
Transmission electron microscopy (TEM) images were
obtained using a JEOL 1010 electron microscope with an
acceleration voltage 100 kV. Scanning electron microscopy
(SEM) images were recorded using a JEOL 6300 microscope
operated at 5–10 kV. Nitrogen sorption isotherms of the
samples were obtained using a Quantachrome's Quadrasorb SI
analyser at 77 K. Before the measurements, the samples were
degassed overnight at 110 C in a vacuum. The Brumauer–
Emmett–Teller (BET) surface area was calculated using exper-
imental points at a relative pressure of P/P0 ¼ 0.05–0.25. The
total pore volume was calculated from the amount of N2
adsorbed at the highest P/P0 (P/P0 ¼ 0.99). The pore size
distribution was calculated using the Broekhoﬀ–de Boer (BdB)
method using a spherical model. The cavity pore size and
entrance pore size are determined from the adsorption and
desorption branches, respectively, using the BdB method. XPS
spectra were recorded on a Kratos Axis Ultra with a mono-
chromatic Al Ka X-ray source. Each spectrum was recorded by a
survey scan from 0 to 1200 eV with a dwell time of 100 ms, a
pass energy of 160 eV at steps of 1 eV with 1 sweep. A high
resolution scan was conducted at a lower pass energy (20 eV),
higher sweep and dwell time at 250 ms. C1s with a binding
energy of 285 eV was used as the reference. The atomic ratio of
the LPMSNs and their functionalised forms (A–MSNs and
PDMAEA–LPMSNs) were determined from XPS spectra and
elemental analysis. Solid state magic-angle spinning (MAS) 13C
nuclear magnetic resonance (NMR) measurements were per-
formed with a Bruker MSL-300 spectrometer operating at aThis journal is © The Royal Society of Chemistry 2014frequency of 75.482 MHz for 13C. The spectrometer was
equipped with a 4 mm double air bearing, magic angle spin-
ning probe for MAS experiments. The proton 90 pulse time
used in the CPMAS method was 5.5 ms, the acquisition time
was 45 ms, cross-polarisation time 2 ms and the relaxation
delay was 3 s. The spectrum width was 50 kHz, and 4000 data
points were collected over 2000 scans. The chemical shis in
the 13C spectrum were referenced to the resonance of
adamantine at 38.23 ppm. All samples were equilibrated at
room temperature (22 C). Zeta potential measurements were
conducted on a Zetasizer Malvern Instrument. TGA/DSC 1
(Mettler-Toledo AG) was used for thermogravimetric analysis
(TGA) at a heating rate of 2 C min1 under a nitrogen ow of
20 ml min1.Results and discussion
Fig. 1A shows the spherical like morphology of LPMSNs with
particle sizes of approximately 100–200 nm. The submicron
spherical morphology can also be conrmed from SEM anal-
ysis (Fig. 2). Nitrogen sorption analysis of the LPMSNs
demonstrates a type IV isotherm with a H2 hysteresis loop at
high relative pressure indicating the existence of large meso-
pores with cage-like structures (Fig. S1†). The size of the
cavities in the LPMSNs was determined to be 11 nm. The main
characteristic of the LPMSNs is the cubic pore structure with a
high degree of pore interconnectivity allowing superior mass
transfer compared to one-dimensional channel-like structures.
This structure also makes the nanoparticles more resistant to
pore blocking.7,15
PDMAEA (Mn  4200) (Fig. S2A†) was attached to the
LPMSNs through a linking azide silane agent (250 Da,
Fig. S2B†). The TEM image of the PDMAEA–LPMSNs (Fig. 1B)
reveals that the functionalization process does not aﬀect the
cubic pore structure. The elemental analysis (EA) indicates that
there is an increase in the atomic percentage of nitrogen (N),
aer azide attachment, to 1.05%. The nitrogen content on the
surface of the LPMSNs was also detected by XPS analysis with an
atomic ratio of 1.33% (Table 1). Similar results are also
conrmed aer PDMAEA attachment. There are signicant
increases in the C and N percentages aer polymer attachment.
The carbon composition rose from 6.9% to 15.5% and 13.6% to
59.5% when measured by EA and XPS analysis respectively. OnJ. Mater. Chem. B, 2014, 2, 718–726 | 721
Fig. 2 SEM image of LPMSNs (scale bar: 1 mm).
Table 1 Chemical composition of the composite PDMAEA–LPMSNs
Elemental analysis XPS
% N % C % H % N % C % O % Si
LPMSNs — 7.54 1.68 — 12.25 62.27 25.47
A–MSNs 1.05 6.99 1.59 1.33 13.62 59.18 25.87
PDMAE–LPMSNs 3.47 15.5 2.86 5.12 59.55 28.77 6.55
Fig. 3 13C CP-MAS-NMR of PDMAEA–LPMSNs.
Journal of Materials Chemistry B Paper
Pu
bl
ish
ed
 o
n 
12
 N
ov
em
be
r 2
01
3.
 D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ity
 o
f Q
ue
en
sla
nd
 on
 30
/01
/20
14
 13
:39
:48
. 
View Article Onlinethe other hand, the nitrogen concentration increased to 3.5%
and 5.1% based on EA and XPS analysis. TGA analysis conrms
that around 5% weight of azide and 16% weight of PDMAEA
have been graed onto the LPMSNs (Fig. S3†).
The details of the surface modication achieved on the silica
materials can be seen from the XPS analyses of N1s for the A–
MSNs and the PDMAEA–LPMSNs (Fig. S4†). Fig. S4A† is a typical
N1s spectrum for azide moieties. There are two peaks repre-
senting N+ species and N species.28 Aer PDMAEA attachment,
only one single peak of N1s is observed (Fig. S4B†). This indi-
cates that most of the nitrogen atoms in the azide groups have
reacted with the alkyne groups of PDMAEA. Thus only C–N
binding from the PDMAEA repeating unit can be detected. That
is why only one single peak, instead of two single peaks, is
observed.
Furthermore, we use 13C NMR analysis to conrm the
successful attachment of PDMAEA and to reveal the molecular
structure of PDMAEA–LPMSN. Fig. 3 shows the solid state 13C
CP-MAS-NMR spectrum of the PDMAEA–LPMSNs. The peaks at
9.5 ppm (C1) represent the covalent attachment of PDMAEA
onto the LPMSNs via azide silane bridges. The peaks of C5, C*
and C7 conrm successful binding between azide groups and
alkyne groups of PDMAEA.29,30 The chemical shis of the 13C
NMR resonances of the PDMAEA–LPMSN samples are compiled
in Table 2. The chemical bindings can be revealed and attrib-
uted to the structure of PDMAEA. In addition, the introduction
of PDMAEA produced positive charges on the silica surface,
resulting in a positive PDMAEA–LPMSN potential value (+20 mV
as compared to LPMSNs with 14.0 mV).
Fig. S1† shows the nitrogen sorption prole of the LPMSNs,
A–MSNs and PDMAEA–LPMSNs. The azide attachment only has
a minor eﬀect on the surface area, pore volume and pore size.722 | J. Mater. Chem. B, 2014, 2, 718–726The values are similar to those for the LPMSNs. For both
samples (LPMSNs and A–MSNs), the surface areas were
approximately 400 m2 g, the pore volume was 0.7 cm3 g1 and
cavity size was approximately 11 nm (Table S1†). However, the
attachment of PDMAEA aﬀected the physical properties. The
BET surface area and pore volume values were reduced quite
signicantly to 105 m2 g1 and 0.32 cm3 g1. We propose that
the high percentage of polymer (16% measured from TGA)
graed onto the pore surface and subsequent pore entrance
blockage is responsible for this reduction.
We designed the PDMAEA to be specically attached on the
MSN surface and not in the pores of the MSN. This makes the
internal pores, which contain hydroxyl groups, accessible for
drug molecules. For this reason, initially azide silane was
graed onto as-synthesized silica materials through a silyla-
tion reaction. The blocked pores of the as-synthesized MSNs
ascertain that azide moieties only attach on the external
surface.31 Aer surfactant removal, azide-MSNs (A–MSNs) were
connected to PDMAEA via a click reaction.29,32 PDMAEA
contains alkyne moieties which can chemically react with
azide groups. The nitrogen sorption analysis (Fig. S1†)
conrms that the attachment of azide only occurs on theThis journal is © The Royal Society of Chemistry 2014
Table 2 Summary of resonance of 13C CP-MAS-NMR spectra for PDMAEA–LPMSNs
PDMAEA–LPMSN C1 C2 C3 C4 C5 C6 C7 C8 C9 C10 C11 C12 C*
Chemical shi (ppm) 9.5 22.7 43.9 174.0 15.9 43.9 42.0 38.0 176.3 70.5 57.7 43.9 111.3
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View Article Onlineexternal surface and does not aﬀect the pore volume or size of
the original LPMSNs.
To determine the binding and release of oligo DNA (mimic
of siRNA) aer conjugation with the PDMAEA–LPMSNs, we
performed an agarose gel retardation assay for PDMAEA–
LPMSN at diﬀerent incubation times (1 and 2 days). Fig. 4
shows the assay for PDMAEA–LPMSNs and PEI–LPMSNs
carried out at diﬀerent N/P ratios (1 and 10) to test the binding
eﬃciency of the nanoparticles. For this experiment, we used
two types of PDMAEA–LPMSN (PDMAEA–LPMSN and
PDMAEA–LPMSN-X) with diﬀerent concentrations. PDMAEA–
LPMSN-X was designed to contain half of the PDMAEA
compared to the PDMAEA–LPMSNs. As a comparison, we also
synthesized a composite of polyethyleneimine (PEI) and
LPMSNs (PEI–LPMSNs). PEI is known to be the most widely
used polycation for gene delivery and has been conjugated
with MSNs for a similar purpose.8,12
As controls,weusedoligo-DNA (lane-1) andLPMSN-oligo-DNA
(lane-2). It was expected that the unbound oligo-DNA which was
released from the particles would be observed as an emerging
band on specic lanes. This band will not be detected as long as
the oligo-DNA binds to the nanoparticles.24 Aer 30 min incu-
bation, a mark can be observed from incomplete binding of oli-
go-DNA with the PDMAEA–LPMSNs and PDMAEA–LPMSN-X at
N/P¼ 1. In contrast, thesemarks were not detected in the case of
the PDMAEA–LPMSNs and PDMAEA–LPMSN-X at N/P ¼ 10.
These results conrmed that a higher N/P ratio is required for
better interactionandcomplete binding of biomolecules. A larger
N/P ratio causes abetter condensation of the complex of PDMAEA
and oligo-DNA.23,24 Thus, a complex of PDMAEA–LPMSN and
oligo-DNAatN/P ratio of 10 showed strong interactionwith oligo-
DNA and maintained the complex stability.Fig. 4 Agarose gel retardation assay of PDMAEA–LPMSN and PEI–
LPMSN after incubation for 30minutes (Day-1) and after storage for 24
hours (Day-2).
This journal is © The Royal Society of Chemistry 2014The stable binding between carrier and oligo-DNA for the
rst few hours is very important to ascertain the delivery of the
siRNA within the cytoplasm.23,24 Interestingly, aer 24 hours
incubation, smearing can be observed in most of the lanes
except for the PEI–MSN lane. PEI is known to be very eﬀective at
complexing with plasmid DNA and siRNA. The multiple amine
moieties within PEI enable strong interactions with the nucleic
acids and cell membrane. Yet, PEI also has some drawbacks
regarding the release of the nucleic acid from the complexes.16,17
The strong binding interaction between PEI and the biomole-
cules hinders release, thus no band is observed from the PEI–
MSN lane. In contrast, smearing can be detected from all the
PDMAEA–LPMSN lanes. In the case of PDMAEA–LPMSN,
PDMAEA is capable of maintaining its ionic strength for the rst
few hours before starting to degrade to non-toxic compounds,
leading to temporary binding of oligo-DNA.23,24 Aer being
released from PDMAEA–LPMSN, oligo-DNA can be observed in
the gel, in agreement with previous reports.23,24 It was found
that the polymer can maintain its binding with DNA for a
suﬃciently long period of time to transfect cells (around 4
hours) and then release the DNA inside the cells aer 10
hours.23,24 Therefore we choose the PDMAEA–LPMSN composi-
tion rather than the conventional PEI functionalization repor-
ted in previous studies.
To enhance siRNA delivery, it is important for the carrier to
escape from endosomal entrapment and deliver siRNA within
the cytoplasm. We introduced Chl into the LPMSN's pores,
which are also known as endosomal-escape inducing mate-
rials.14,19 Chl is weakly basic and can be attracted with nega-
tively charged silanol groups. It is very soluble in water, with
solubilities up to 1 mg ml1.14,33 However, the nature of the
PDMAEA–LPMSNs which can be degraded in water makes the
adsorption of Chl into PDMAEA–LPMSN in water impracti-
cable. In addition, the nitrogen sorption shows that most of
the entrance pores have been blocked aer PDMAEA attach-
ment, suggesting that the adsorption of Chl aer polymer
attachment is diﬃcult. To optimize Chl adsorption, we carried
out the adsorption aer azide attachment (Scheme 1).
Following surfactant removal, the pores of the azide–MSNs
were accessible to Chl. The adsorption of Chl onto A–MSNs
was conducted in water for 24 hours.33 Then, PDMAEA
attachment was carried in toluene. The loading amount of Chl
in the PDMAEA–LPMSNs, based on UV analysis was 100 mg
g1, (0.1 mg mg1 MSNs).
As shown in Scheme 1, PDMAEA–LPMSN is designed to co-
deliver siRNA and Chl in a controllable manner. Aer PDMAEA
degradation, not only can the siRNA be released, but also the
release of Chl is accelerated following the rupture of PDMAEA on
the MSN’s surface, which promotes endosomal escape of siRNA
within the cytoplasm.Toevaluate the cytotoxicity of the composite
materials (PDMAEA–LPMSN and Chl–PDMAEA–LPMSN), weJ. Mater. Chem. B, 2014, 2, 718–726 | 723
Scheme 1 Detailed mechanism of chloroquine loading and siRNA binding for dual delivery.
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View Article Onlinetested the eﬀect of the particle's concentration on KHOS cell
viability. Fig. 5 shows that the composite materials induced
negligible toxicity, even at a very high concentration 400 mg ml1.
The half maximal inhibitory concentration (IC50) values of
PDMAEA–LPMSN and Chl–PDMAEA–LPMSN were similar,
approximately 1200 mg ml1, which can be explained by the very
low toxicity of PDMAEA23,24 and unmodied LPMSNs.15
Similarly to PDMAEA–LPMSNs, Chl–PDMAEA–LPMSNs did
not aﬀect the cell viability. This is in agreement with a previous
report which showed that Chl loaded MSNs with a loading
amount 0.15 mg mg1 (close to Chl–PDMAEA–LPMSN, 0.1 mg
mg1) have negligible eﬀect on cytotoxicity.14 Our ndings
conrm that both PDMAEA–LPMSN and Chl-PDMAEA–LPMSN
are safe to be used even at high concentrations.
Fig. 6 illustrates the cell uptake study of PDMAEA–LPMSN
and Chl–PDMAEA–LPMSN. Confocal microscopy was used to
observe the internalization of the particles. Firstly, all particlesFig. 5 Cytotoxicity test for PDMAEA–LPMSN and Chl–PDMAEA–
LPMSN.
724 | J. Mater. Chem. B, 2014, 2, 718–726were conjugated with oligo-DNA, they were then incubated
with KHOS cell lines. To adequately follow adsorption and the
cell internalization process, the oligo-DNA was labeled with
cyanine dye (Cy3-oligo-DNA) to show red uorescence. Cy3-
oligo-DNA itself without any nano-carriers did not show any
red signal coming from Cy3, similar to that observed in the
control group without any treatment. The blue signals
observed were from DAPI stained nuclei. In contrast, both
PDMAEA–LPMSNs and Chl-PDMAEA–LPMSNs conjugated with
Cy3-oligo-DNA reveal red signals. These results demonstrated
that the negatively charged oligo-DNA themselves cannot enter
into the cells, while the functional nanoparticles (PDMAEA–
LPMSNs and Chl-PDMAEA–LPMSNs) have the capacity to
deliver the genetic molecules into the cells.
The polycation PDMAEA interacts with oligo-DNA and
also the cell’s membrane, essential for cellular uptake.8,15
Compared to PDMAEA–LPMSNs, it was observed that
Chl–PDMAEA–LPMSNs showed a stronger and more homo-
geneous Cy3 signal. It is known that Chl is a DNA intercalator
which has preferential binding towards the G-C sequence.34
We propose that Chl located adjacent to the external surface
of the LPMSNs might improve the binding to oligo-DNA
molecules. The stronger binding causes more oligo-DNA to be
carried and delivered into the cells. Aer cellular uptake, Chl
induces endosomal escape by its buﬀering capability.14
Consequently, the red signal coming from Cy3 is distributed
homogeneously in the cytoplasm. In contrast, without Chl,
the carriers are localised within discrete spots (see also
Fig. 6).34
The ability of PDMAEA–LPMSN to co-deliver bio-functional
siRNA and chloroquine (Chl) was investigated by using PLK1-
siRNA against polo-like kinase 1 and testing the cell toxicity in an
osteosarcoma cell line, KHOS. Fig. 7 conrms that PDMAEA–
LPMSN as a carrier has a negligible cell inhibition performance.
Our previous study showed that PDMAEA as a single carrier has a
low endosomal escape property,25 indicating that the siRNAs
delivered by PDMAEA–LPMSNs, similarly to PDMAEA, cannotThis journal is © The Royal Society of Chemistry 2014
Fig. 6 Assessment of cell uptake by confocal microscopy. The cell uptake eﬃciency of PDMAEA–LPMSN and Chl–PDMAEA–LPMSN were
examined by labeling the particles with a 21-nt oligo-DNA conjugated with Cy-3.
Fig. 7 Biological function analysis of PDMAEA–LPMSN and Chl–
PDMAEA–LPMSN based on delivering PLK1 siRNA in KHOS cells.
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View Article Onlineescape from endosomal entrapment to induce a silencing
eﬀect.25 In contrast, Chl–PDMAEA–LPMSN induces a reasonably
signicant decrease in cellular viability (25%). Our results haveThis journal is © The Royal Society of Chemistry 2014shown that although the actual benet of PDMAEA as a single
carrier for gene silencing is limited,25 the conjugation with
LPMSNs oﬀersmore opportunities for the fabrication of eﬀective
and multi-functional nano-carriers.Conclusion
In this study, a novel gene carrier with selected properties:
degradability, low toxicity and high capacity was prepared by
graing “self-catalyzed degradation” PDMAEA onto the surface
of large pore and cubic mesostructured mesoporous silica
nanoparticles to produce an eﬃcient gene carrier: PDMAEA–
LPMSNs. The composite materials have very low toxicity even at
a very high concentration of 400 mg ml1. The degradable
PDMAEA enables the release of siRNA aer endocytosis. The
chloroquine loaded inside the nanopores allows the cargo
molecules to escape from endosomal entrapment. These results
demonstrate the potential of PDMAEA–LPMSNs as a gene
carrier. To fully utilise the potential of PDMAEA–LPMSNs, it is
expected that chemotherapy drugs could also be carried,
oﬀering multi-functional nano-carriers for dual delivery
applications.J. Mater. Chem. B, 2014, 2, 718–726 | 725
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Fig. S1 Nitrogen sorption curves of LPMSN, A-MSN and PDMAEA-LPMSN 
Table S1 Physicochemical properties of samples  
Sample BET Surface Area 
 (m
2
/g) 
Pore Volume  
(cc/g) 
Cavity  
(nm) 
LPMSN 451 0.70 11.0 
A-MSN 415 0.67 11.0 
PDMAEA-LPMSN 105 0.32 10.2 
Electronic Supplementary Material (ESI) for Journal of Materials Chemistry B
This journal is © The Royal Society of Chemistry 2013
 2 
 
 
 
              
Fig. S2 2-azido-N-(3-(triethoxy silyl)propyl)propanamide or Azide silane (A) and poly(2-
dimethylaminoethyl acrylate) (PDMAEA) (B) 
 
 
Fig. S3 TGA analysis of LPMSN and functionalised LPMSN 
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Fig. S4 High resolution XPS analysis of N1s spectra for (A) A-MSN and (B) PDMAEA-LPMSN 
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